Elham Kayvanpour

3.7k total citations
56 papers, 1.3k citations indexed

About

Elham Kayvanpour is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Elham Kayvanpour has authored 56 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Cardiology and Cardiovascular Medicine, 16 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Elham Kayvanpour's work include Cardiomyopathy and Myosin Studies (22 papers), Cardiovascular Function and Risk Factors (10 papers) and Viral Infections and Immunology Research (9 papers). Elham Kayvanpour is often cited by papers focused on Cardiomyopathy and Myosin Studies (22 papers), Cardiovascular Function and Risk Factors (10 papers) and Viral Infections and Immunology Research (9 papers). Elham Kayvanpour collaborates with scholars based in Germany, United States and Iran. Elham Kayvanpour's co-authors include Farbod Sedaghat‐Hamedani, Benjamin Meder, Hugo A. Katus, Jan Haas, Andreas Keller, Ali Amr, Katrin Jensen, Karen Frese, Alan Lai and Britta Vogel and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Elham Kayvanpour

54 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elham Kayvanpour Germany	18	762	536	288	121	96	56	1.3k
Farbod Sedaghat‐Hamedani Germany	18	712 0.9×	603 1.1×	335 1.2×	119 1.0×	87 0.9×	58	1.4k
Meng Jiang China	19	456 0.6×	412 0.8×	219 0.8×	291 2.4×	260 2.7×	82	1.3k
Fragiskos Parthenakis Greece	20	803 1.1×	272 0.5×	163 0.6×	262 2.2×	130 1.4×	84	1.3k
Karla Kurrelmeyer United States	12	935 1.2×	448 0.8×	117 0.4×	214 1.8×	156 1.6×	25	1.4k
Dirk Jan van Veldhuisen Netherlands	14	1.2k 1.5×	496 0.9×	62 0.2×	232 1.9×	155 1.6×	36	1.7k
Jonas Carlson Sweden	26	1.4k 1.8×	219 0.4×	78 0.3×	120 1.0×	131 1.4×	98	2.1k
Moritz F. Sinner Germany	24	1.8k 2.3×	669 1.2×	134 0.5×	125 1.0×	82 0.9×	64	2.2k
Shigeki Kimura Japan	20	655 0.9×	263 0.5×	75 0.3×	317 2.6×	209 2.2×	102	1.3k
Gerardus P. J. van Hout Netherlands	15	332 0.4×	480 0.9×	49 0.2×	336 2.8×	65 0.7×	33	948

Countries citing papers authored by Elham Kayvanpour

Since Specialization

Citations

This map shows the geographic impact of Elham Kayvanpour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elham Kayvanpour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elham Kayvanpour more than expected).

Fields of papers citing papers by Elham Kayvanpour

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elham Kayvanpour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elham Kayvanpour. The network helps show where Elham Kayvanpour may publish in the future.

Co-authorship network of co-authors of Elham Kayvanpour

This figure shows the co-authorship network connecting the top 25 collaborators of Elham Kayvanpour. A scholar is included among the top collaborators of Elham Kayvanpour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elham Kayvanpour. Elham Kayvanpour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kayvanpour, Elham, Ziya Kaya, Sven T. Pleger, et al.. (2025). Efficacy and Safety of Percutaneous ASD Closure in Adults: Comparative Outcomes of Occluder Devices in a Single-Center Cohort. Journal of Clinical Medicine. 14(6). 1867–1867. 1 indexed citations

Sedaghat‐Hamedani, Farbod, Ali Amr, Elham Kayvanpour, et al.. (2024). Personalized Care in Dilated Cardiomyopathy: Rationale and Study Design of the activeDCM Trial. ESC Heart Failure. 11(6). 4400–4406. 5 indexed citations

Sedaghat‐Hamedani, Farbod, Oliver Heinze, Ali Amr, et al.. (2024). A Remote Patient Monitoring System With Feedback Mechanisms Using a Smartwatch: Concept, Implementation, and Evaluation Based on the activeDCM Randomized Controlled Trial. JMIR mhealth and uhealth. 12. e58441–e58441. 3 indexed citations

Kayvanpour, Elham, Ziya Kaya, Sven T. Pleger, et al.. (2024). Comparative Effectiveness of Devices for Interventional Patent Foramen Ovale Closure: Insights from a 23-Year Monocentric Analysis. Journal of Clinical Medicine. 13(21). 6354–6354. 1 indexed citations

Kayvanpour, Elham, Farbod Sedaghat‐Hamedani, Tanja Weis, et al.. (2024). Prognostic Value of Circulating Fibrosis Biomarkers in Dilated Cardiomyopathy (DCM): Insights into Clinical Outcomes. Biomolecules. 14(9). 1137–1137. 4 indexed citations

Amr, Ali, Farbod Sedaghat‐Hamedani, Elham Kayvanpour, et al.. (2023). Improving sudden cardiac death risk stratification in hypertrophic cardiomyopathy using established clinical variables and genetic information. Clinical Research in Cardiology. 113(5). 728–736. 10 indexed citations

Sedaghat‐Hamedani, Farbod, et al.. (2023). Generation of an RBM20-mutation-associated left-ventricular non-compaction cardiomyopathy iPSC line (UMGi255-A) into a DCM genetic background to investigate monogenetic cardiomyopathies. Stem Cell Research. 74. 103290–103290. 2 indexed citations

Pepin, Mark E., Markus Grosch, Sandra Clauder‐Münster, et al.. (2022). Deep phenotyping of two preclinical mouse models and a cohort of RBM20 mutation carriers reveals no sex-dependent disease severity in RBM20 cardiomyopathy. American Journal of Physiology-Heart and Circulatory Physiology. 323(6). H1296–H1310. 7 indexed citations

Tappu, Rewati, Jan Haas, David Lehmann, et al.. (2022). Multi-omics assessment of dilated cardiomyopathy using non-negative matrix factorization. PLoS ONE. 17(8). e0272093–e0272093. 6 indexed citations

10.

Sedaghat‐Hamedani, Farbod, et al.. (2020). Generation of pluripotent stem cell lines and CRISPR/Cas9 modified isogenic controls from a patient with dilated cardiomyopathy harboring a RBM20 p.R634W mutation. Stem Cell Research. 47. 101901–101901. 10 indexed citations

11.

Sammani, Arjan, Elham Kayvanpour, Laurens P. Bosman, et al.. (2020). Predicting Sustained Ventricular Arrhythmias in Dilated Cardiomyopathy: A Meta-Analysis and Systematic Review. ESC Heart Failure. 7(4). 1430–1441. 24 indexed citations

12.

Sedaghat‐Hamedani, Farbod, Elham Kayvanpour, Lutz Frankenstein, et al.. (2019). The Chameleon of Cardiology: Cardiac Sarcoidosis Before and After Heart Transplantation. ESC Heart Failure. 7(2). 692–696. 8 indexed citations

13.

Arenja, Nisha, Johannes Riffel, Thomas Fritz, et al.. (2017). The prognostic value of right ventricular long axis strain in non-ischaemic dilated cardiomyopathies using standard cardiac magnetic resonance imaging. European Radiology. 27(9). 3913–3923. 20 indexed citations

14.

Nietsch, Rouven, Jan Haas, Alan Lai, et al.. (2016). The Role of Quality Control in Targeted Next-Generation Sequencing Library Preparation. Genomics Proteomics & Bioinformatics. 14(4). 200–206. 7 indexed citations

15.

Ali‐Hasan‐Al‐Saegh, Sadeq, Seyed Jalil Mirhosseini, Ali Dehghan, et al.. (2016). Protective effects of anti-oxidant supplementations on contrast-induced nephropathy after coronary angiography: an updated and comprehensive meta-analysis and systematic review. Kardiologia Polska. 74(7). 610–626. 10 indexed citations

16.

Kayvanpour, Elham, Farbod Sedaghat‐Hamedani, Ali Amr, et al.. (2016). Genotype-phenotype associations in dilated cardiomyopathy: meta-analysis on more than 8000 individuals. Clinical Research in Cardiology. 106(2). 127–139. 157 indexed citations

17.

Mirhosseini, Seyed Jalil, Farbod Sedaghat‐Hamedani, Elham Kayvanpour, et al.. (2015). Administration of erythropoietin in patients with myocardial infarction: does it make sense? An updated and comprehensive meta-analysis and systematic review. Cardiovascular revascularization medicine. 16(3). 179–189. 12 indexed citations

18.

Sedaghat‐Hamedani, Farbod, Edgar Zitron, Elham Kayvanpour, et al.. (2014). Post cardiac injury syndrome after initially uncomplicated CRT-D implantation: a case report and a systematic review. Clinical Research in Cardiology. 103(10). 781–789. 20 indexed citations

19.

Mirhosseini, Seyed Jalil, Hamidreza Dehghan, Farbod Sedaghat‐Hamedani, et al.. (2014). Antioxidant supplementations for prevention of atrial fibrillation after cardiac surgery: an updated comprehensive systematic review and meta-analysis of 23 randomized controlled trials. Interactive Cardiovascular and Thoracic Surgery. 18(5). 646–654. 51 indexed citations

20.

Meder, Benjamin, Andreas Keller, Britta Vogel, et al.. (2010). MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction. Basic Research in Cardiology. 106(1). 13–23. 216 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact